ESAB Corporation enters partnership with GRI to promote sustainability
ESAB Corporation (NYSE: ESAB), a world leader in connected fabrication technology and gas control solutions, and GRI Renewable Industries, a global leading manufacturer of wind turbine components, have entered a new partnership to collaborate on green projects in support of their mutual commitment to running sustainable businesses. The partnership will leverage each company’s expertise in the fabrication and wind power industries to drive initiatives such as the transition to green energy and the reduction of each company’s environmental footprint.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230712662690/en/
ESAB Corporation announced today it has entered a new partnership with GRI Renewable Industries, a global leading manufacturer of wind turbine components. The two companies will collaborate on green projects in support of their mutual commitment to running sustainable businesses, including the transition to green energy and the reduction of each company’s environmental footprint. Pictured here: Olivier Biebuyck, President of ESAB Corporation’s Fabrication Technology platform; Antonio Barbosa, CEO at GRI Renewable Energy Industries; ESAB Corporation CEO, Shyam P. Kambeyanda. (Photo: Business Wire)
“ESAB is thrilled to build on our relationship with GRI, one of our long-standing customers, to develop and implement innovative solutions that will decrease our environmental impact,” said Shyam P. Kambeyanda, President and CEO, ESAB Corporation. “Our two companies share a commitment to reducing greenhouse gas emissions and creating eco-friendly products that make our world a better place to live, which aligns with ESAB’s purpose of Shaping the world we imagine.”
Antonio Barbosa, CEO at GRI Renewable Energy Industries, said: “The renewable energy sector is a pillar in the decarbonization of the economy, and GRI Renewable Industries, as a committed player in this sector, considers the value chain greenhouse gas emission reduction in the wind energy sector as a key element in the company strategy and purpose: Doing well by doing Green. This partnering agreement with ESAB will enable us to develop processes and products together.”
About ESAB Corporation
Founded in 1904, ESAB Corporation (NYSE: ESAB) is a world leader in connected fabrication technology and gas control solutions. Its rich history of innovative products, workflow solutions, and business system (EBX) allows the company to realize its purpose of Shaping the world we imagine. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 9,000 associates, and serves customers in approximately 150 countries. To learn more, visit www.ESABcorporation.com .
About GRI
Since 2008, GRI Renewable Industries ( www.gri.com.es ) has been developing its core business of manufacturing wind towers and flanges in the wind energy sector. Currently, it has 18 manufacturing plants in Spain, USA, Brazil, Argentina, China, Turkey, India, and South Africa supplying high-quality wind towers and flanges to the wind energy industry worldwide. The company closed 2022 with sales around 1,200 million euros and over 5,500 employees.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230712662690/en/
Contact information
ESAB Media Contact:
Tilea Coleman
Vice President, Corporate Communications
E-mail: mediarelations@esab.com
Phone: 1-301-323-9092
GRI Media Contact:
Juan Llovet
Sustainability & Communications Director
Email: juan.llovet@gonvarri.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom